Research Articles
A Researcher's Guide to Public Cancer DNA Sequencing Datasets: Access, Analysis, and Application
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on leveraging public datasets for cancer DNA sequence analysis.
Gene Expression Analysis in Early Cancer Detection: From Biomarkers to AI-Driven Clinical Applications
This article provides a comprehensive analysis of the role of gene expression analysis in early cancer detection for researchers, scientists, and drug development professionals.
Beyond Accuracy: A Comprehensive Guide to Performance Metrics for Cancer Classification Models
This article provides a comprehensive guide to performance metrics for cancer classification models, tailored for researchers, scientists, and drug development professionals.
Beyond Stability: Rethinking Test-Retest Reliability in Radiomics for Robust Biomarker Development
This article provides a comprehensive examination of test-retest reliability in radiomic features, a critical foundation for developing robust imaging biomarkers.
Traditional vs. AI-Based Cancer Diagnostics: A Comparative Analysis for Biomedical Research
This article provides a comprehensive comparison for researchers and drug development professionals between traditional cancer diagnostics and emerging artificial intelligence (AI)-based approaches.
Beyond Single-Center Success: A Comprehensive Framework for Validating AI Models on Multi-Center Datasets
The translation of artificial intelligence (AI) models from promising research tools to reliable clinical assets hinges on robust validation across diverse, multi-center datasets.
Benchmarking Cancer Imaging Foundation Models: A Comprehensive Guide for Researchers and Clinicians
This article provides a systematic review of the current landscape, methodologies, and challenges in benchmarking foundation models for cancer imaging.
Beyond the Black Box: A Practical Guide to Model Interpretability for Clinical Acceptance in Drug Development
The integration of artificial intelligence and machine learning into drug development promises to revolutionize the industry by accelerating discovery and optimizing clinical trials.
Overcoming Data Scarcity in Drug Discovery: A Self-Supervised Learning Revolution
This article explores the transformative potential of self-supervised learning (SSL) to overcome the critical challenge of data scarcity in drug discovery and development.
Reducing False Positives in Cancer Screening: AI-Driven Strategies for Improved Diagnostic Accuracy and Patient Outcomes
This article examines the critical challenge of false positives in cancer screening and explores the transformative role of Artificial Intelligence (AI) in addressing this issue.